{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:50:40Z","timestamp":1791341440884,"version":"4.3.1"},"reference-count":44,"publisher":"American Society of Hematology","issue":"18","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Human herpesvirus 6 (HHV-6) can reactivate after allogeneic hematopoietic stem cell transplant (allo-HSCT) and may lead to severe symptoms. HHV-6\u2013specific immune responses after HSCT are largely unexplored. We conducted a prospective observational study on 208 consecutive adult patients who received allo-HSCT to investigate HHV-6 reactivations and specific immune responses. Interferon gamma\u2013producing HHV-6\u2013specific T cells were quantified using enzyme-linked immunospot assay (ELISpot). HHV-6 reactivation occurred in 63% of patients, at a median of 25 days from allo-HSCT. Only 40% of these presented a clinically relevant infection, defined by the presence of classical HHV-6 end-organ diseases (EODs), based on European Conference on Infections in Leukaemia (ECIL) guidelines, and other possible HHV6-related EODs. Using multivariate analysis, we identified risk factors for HHV-6 reactivation: previous allo-HSCT, posttransplant cyclophosphamide (PT-Cy), and time-dependent steroids introduction. The use of PT-Cy and steroids were associated with clinically relevant infections, whereas higher CD3+ cell counts seemed to be protective. Interestingly, circulating HHV-6\u2013specific T cells were significantly higher in patients with reactivated virus. Moreover, HHV-6\u2013specific T-cell responses, quantified at &amp;gt;4 days after the first viremia detection, predicted clinically relevant infections (P\u00a0&amp;lt; .0001), with higher specificity (93%) and sensitivity (79%) than polyclonal CD3+ cells per \u03bcL. Overall survival and transplant-related mortality were not affected by time-dependent HHV-6 reactivation, whereas a significant association was observed between clinically relevant infections and acute graft-versus-host disease. These results shed light on the role of HHV-6 in allo-HSCT and may affect HHV-6 monitoring and treatment.<\/jats:p>","DOI":"10.1182\/bloodadvances.2022009274","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T12:24:39Z","timestamp":1681734279000},"page":"5446-5457","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":35,"title":["Human herpesvirus 6\u2013specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3252-8876","authenticated-orcid":false,"given":"Maddalena","family":"Noviello","sequence":"first","affiliation":[{"name":"1Experimental Hematology Unit, Division of Immunology, Transplantation and Infectious Diseases, Milano, Italy"},{"name":"2Cell Therapy Immunomonitoring Laboratory, Division of Immunology, Transplantation and Infectious Diseases, Ospedale San Raffaele Scientific Institute, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Lorentino","sequence":"additional","affiliation":[{"name":"3Haematology and Bone Marrow Transplant Unit, Ospedale San Raffaele Scientific Institute, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Xue","sequence":"additional","affiliation":[{"name":"3Haematology and Bone Marrow Transplant Unit, Ospedale San Raffaele Scientific Institute, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Racca","sequence":"additional","affiliation":[{"name":"4Laboratory of Microbiology and Virology, Ospedale San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Furnari","sequence":"additional","affiliation":[{"name":"5Universit\u00e0 Vita-Salute San Raffaele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Valtolina","sequence":"additional","affiliation":[{"name":"1Experimental Hematology Unit, Division of Immunology, Transplantation and Infectious Diseases, Milano, Italy"},{"name":"2Cell Therapy Immunomonitoring Laboratory, Division of Immunology, Transplantation and Infectious Diseases, Ospedale San Raffaele Scientific Institute, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Campodonico","sequence":"additional","affiliation":[{"name":"3Haematology and Bone Marrow Transplant Unit, Ospedale San Raffaele Scientific Institute, Milano, Italy"},{"name":"5Universit\u00e0 Vita-Salute San Raffaele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roee","family":"Dvir","sequence":"additional","affiliation":[{"name":"4Laboratory of Microbiology and Virology, Ospedale San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1382-6939","authenticated-orcid":false,"given":"Maria Teresa","family":"Lupo-Stanghellini","sequence":"additional","affiliation":[{"name":"3Haematology and Bone Marrow Transplant Unit, Ospedale San Raffaele Scientific Institute, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4755-9533","authenticated-orcid":false,"given":"Fabio","family":"Giglio","sequence":"additional","affiliation":[{"name":"3Haematology and Bone Marrow Transplant Unit, Ospedale San Raffaele Scientific Institute, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Piemontese","sequence":"additional","affiliation":[{"name":"3Haematology and Bone Marrow Transplant Unit, Ospedale San Raffaele Scientific Institute, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Clerici","sequence":"additional","affiliation":[{"name":"3Haematology and Bone Marrow Transplant Unit, Ospedale San Raffaele Scientific Institute, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Oltolini","sequence":"additional","affiliation":[{"name":"6Infectious Disease Unit, Ospedale San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Tassi","sequence":"additional","affiliation":[{"name":"1Experimental Hematology Unit, Division of Immunology, Transplantation and Infectious Diseases, Milano, Italy"},{"name":"2Cell Therapy Immunomonitoring Laboratory, Division of Immunology, Transplantation and Infectious Diseases, Ospedale San Raffaele Scientific Institute, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Beretta","sequence":"additional","affiliation":[{"name":"1Experimental Hematology Unit, Division of Immunology, Transplantation and Infectious Diseases, Milano, Italy"},{"name":"2Cell Therapy Immunomonitoring Laboratory, Division of Immunology, Transplantation and Infectious Diseases, Ospedale San Raffaele Scientific Institute, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Farina","sequence":"additional","affiliation":[{"name":"3Haematology and Bone Marrow Transplant Unit, Ospedale San Raffaele Scientific Institute, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Mannina","sequence":"additional","affiliation":[{"name":"3Haematology and Bone Marrow Transplant Unit, Ospedale San Raffaele Scientific Institute, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ardemagni","sequence":"additional","affiliation":[{"name":"4Laboratory of Microbiology and Virology, Ospedale San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4247-3175","authenticated-orcid":false,"given":"Luca","family":"Vago","sequence":"additional","affiliation":[{"name":"5Universit\u00e0 Vita-Salute San Raffaele, Milan, Italy"},{"name":"7Unit of Immunogenetics, Leukemia Genomics and Immunobiology, Ospedale San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1334-0851","authenticated-orcid":false,"given":"Massimo","family":"Bernardi","sequence":"additional","affiliation":[{"name":"3Haematology and Bone Marrow Transplant Unit, Ospedale San Raffaele Scientific Institute, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4377-8571","authenticated-orcid":false,"given":"Consuelo","family":"Corti","sequence":"additional","affiliation":[{"name":"3Haematology and Bone Marrow Transplant Unit, Ospedale San Raffaele Scientific Institute, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Peccatori","sequence":"additional","affiliation":[{"name":"3Haematology and Bone Marrow Transplant Unit, Ospedale San Raffaele Scientific Institute, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Clementi","sequence":"additional","affiliation":[{"name":"4Laboratory of Microbiology and Virology, Ospedale San Raffaele Scientific Institute, Milan, Italy"},{"name":"5Universit\u00e0 Vita-Salute San Raffaele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Ciceri","sequence":"additional","affiliation":[{"name":"3Haematology and Bone Marrow Transplant Unit, Ospedale San Raffaele Scientific Institute, Milano, Italy"},{"name":"5Universit\u00e0 Vita-Salute San Raffaele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Bonini","sequence":"additional","affiliation":[{"name":"1Experimental Hematology Unit, Division of Immunology, Transplantation and Infectious Diseases, Milano, Italy"},{"name":"2Cell Therapy Immunomonitoring Laboratory, Division of Immunology, Transplantation and Infectious Diseases, Ospedale San Raffaele Scientific Institute, Milano, Italy"},{"name":"5Universit\u00e0 Vita-Salute San Raffaele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6117-5328","authenticated-orcid":false,"given":"Raffaella","family":"Greco","sequence":"additional","affiliation":[{"name":"3Haematology and Bone Marrow Transplant Unit, Ospedale San Raffaele Scientific Institute, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,9,15]]},"reference":[{"issue":"7","key":"2023092214050212800_bib1","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/s41409-021-01227-8","article-title":"Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years","volume":"56","author":"Passweg","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"16","key":"2023092214050212800_bib2","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood-2016-10-748426","article-title":"The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality","volume":"129","author":"Hill","year":"2017","journal-title":"Blood"},{"issue":"1","key":"2023092214050212800_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/transplantology2010002","article-title":"Management of herpesvirus infections in hematopoietic cell transplant recipients","volume":"2","author":"Styczynski","year":"2021","journal-title":"Transplantology"},{"issue":"6","key":"2023092214050212800_bib4","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.bbmt.2020.01.013","article-title":"Infections after allogenic transplant with post-transplant cyclophosphamide: impact of donor HLA matching","volume":"26","author":"Oltolini","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2023092214050212800_bib5","doi-asserted-by":"crossref","first-page":"48.e1","DOI":"10.1016\/j.jtct.2021.09.015","article-title":"Post-transplantation cyclophosphamide is associated with an increase in non-cytomegalovirus herpesvirus infections in patients with acute leukemia and myelodysplastic syndrome","volume":"28","author":"Singh","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"2023092214050212800_bib6","first-page":"20","article-title":"Human herpesvirus 6: a clinical update","volume":"13","author":"Zerr","year":"2006","journal-title":"Herpes"},{"issue":"4","key":"2023092214050212800_bib7","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1182\/bloodadvances.2017012724","article-title":"Human herpesvirus 6 viremia affects T-cell reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"2","author":"de Koning","year":"2018","journal-title":"Blood Adv"},{"issue":"11","key":"2023092214050212800_bib8","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.3324\/haematol.2019.223073","article-title":"Guidelines from the 2017 European Conference on infections in leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation","volume":"104","author":"Ward","year":"2019","journal-title":"Haematologica"},{"issue":"5","key":"2023092214050212800_bib9","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1182\/blood.V94.5.1545.417a25_1545_1549","article-title":"Inheritance of chromosomally integrated human herpesvirus 6 DNA","volume":"94","author":"Daibata","year":"1999","journal-title":"Blood"},{"issue":"11","key":"2023092214050212800_bib10","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.bbmt.2012.04.016","article-title":"Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis","volume":"18","author":"Hill","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"2023092214050212800_bib11","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/bmt.2017.175","article-title":"Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation","volume":"52","author":"Ogata","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"17","key":"2023092214050212800_bib12","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1182\/blood.2019004315","article-title":"Oral brincidofovir decreases the incidence of HHV-6B viremia after allogeneic HCT","volume":"135","author":"Hill","year":"2020","journal-title":"Blood"},{"issue":"9","key":"2023092214050212800_bib13","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1128\/JVI.06573-11","article-title":"Human CD4+ T cell response to human herpesvirus 6","volume":"86","author":"Nastke","year":"2012","journal-title":"J\u00a0Virol"},{"key":"2023092214050212800_bib14","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.3389\/fimmu.2018.01454","article-title":"Advances in the characterization of the T-cell response to human herpesvirus-6","volume":"9","author":"Hanson","year":"2018","journal-title":"Front Immunol"},{"issue":"11","key":"2023092214050212800_bib15","doi-asserted-by":"crossref","first-page":"e0142871","DOI":"10.1371\/journal.pone.0142871","article-title":"A\u00a0simple proteomics-based approach to identification of immunodominant antigens from a complex pathogen: application to the CD4\u00a0T cell response against human herpesvirus 6B","volume":"10","author":"Becerra-Artiles","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"2023092214050212800_bib16","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s10875-021-01205-1","article-title":"Antiviral T-cell frequencies in a healthy population: reference values for evaluating antiviral immune cell profiles in immunocompromised patients","volume":"42","author":"Schulze Lammers","year":"2022","journal-title":"J\u00a0Clin Immunol"},{"issue":"1","key":"2023092214050212800_bib17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1182\/blood-2012-05-430413","article-title":"Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation","volume":"121","author":"Gerdemann","year":"2013","journal-title":"Blood"},{"issue":"3","key":"2023092214050212800_bib18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.clim.2012.06.006","article-title":"First analysis of human herpesvirus 6T-cell responses: specific boosting after HHV6 reactivation in stem cell transplantation recipients","volume":"144","author":"de Pagter","year":"2012","journal-title":"Clin Immunol"},{"issue":"6","key":"2023092214050212800_bib19","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jaci.2016.12.992","article-title":"Viral reactivations and associated outcomes in the context of immune reconstitution after pediatric hematopoietic cell transplantation","volume":"140","author":"Admiraal","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"12","key":"2023092214050212800_bib20","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1016\/j.bbmt.2016.09.018","article-title":"Human herpesvirus 6 infection following haploidentical transplantation: immune recovery and outcome","volume":"22","author":"Greco","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2023092214050212800_bib21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/infdis\/jiaa422","article-title":"Donor-derived CD4+ T cells and human herpesvirus 6B detection after allogeneic hematopoietic cell transplantation","volume":"223","author":"Hanson","year":"2021","journal-title":"J\u00a0Infect Dis"},{"issue":"12","key":"2023092214050212800_bib22","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: working definitions","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"2023092214050212800_bib23","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.3324\/haematol.2020.268839","article-title":"Dose intensity for conditioning in allogeneic hematopoietic cell transplantation: can we recommend \"when and for whom\" in 2021?","volume":"106","author":"Gagelmann","year":"2021","journal-title":"Haematologica"},{"issue":"9","key":"2023092214050212800_bib24","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.3324\/haematol.2011.043810","article-title":"Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an International Prospective Phase II Trial","volume":"96","author":"Ruutu","year":"2011","journal-title":"Haematologica"},{"issue":"2","key":"2023092214050212800_bib25","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/leu.2014.180","article-title":"Sirolimus-based graft-versus-host disease prophylaxis promotes the in\u00a0vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors","volume":"29","author":"Peccatori","year":"2015","journal-title":"Leukemia"},{"issue":"3","key":"2023092214050212800_bib26","doi-asserted-by":"crossref","first-page":"e13836","DOI":"10.1111\/tid.13836","article-title":"Detection of human herpesvirus 6 DNA and chromosomal integration after allogeneic hematopoietic stem cell transplantation: a retrospective single center analysis","volume":"24","author":"Berneking","year":"2022","journal-title":"Transpl Infect Dis"},{"issue":"9","key":"2023092214050212800_bib27","doi-asserted-by":"crossref","first-page":"776.e1","DOI":"10.1016\/j.jtct.2021.05.023","article-title":"Posttransplantation cyclophosphamide- and sirolimus-based graft-versus-host-disease prophylaxis in allogeneic stem cell transplant","volume":"27","author":"Greco","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"12","key":"2023092214050212800_bib28","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1084\/jem.20042408","article-title":"Repertoire, diversity, and differentiation of specific CD8\u00a0T cells are associated with immune protection against human cytomegalovirus disease","volume":"201","author":"Sacre","year":"2005","journal-title":"J\u00a0Exp Med"},{"issue":"242","key":"2023092214050212800_bib29","doi-asserted-by":"crossref","first-page":"242ra83","DOI":"10.1126\/scitranslmed.3008825","article-title":"Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT","volume":"6","author":"Papadopoulou","year":"2014","journal-title":"Sci Transl Med"},{"issue":"9","key":"2023092214050212800_bib30","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/bmt.2015.132","article-title":"Early recovery of CMV immunity after HLA-haploidentical hematopoietic stem cell transplantation as a surrogate biomarker for a reduced risk of severe infections overall","volume":"50","author":"Noviello","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"2023092214050212800_bib31","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.bbmt.2011.12.579","article-title":"Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study","volume":"18","author":"Dulery","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"2023092214050212800_bib32","first-page":"20499361211018027","article-title":"Post-allogeneic hematopoietic stem cell transplantation viral reactivations and viremias: a focused review on human herpesvirus-6, BK virus and adenovirus","volume":"8","author":"Wang","year":"2021","journal-title":"Ther Adv Infect Dis"},{"issue":"8","key":"2023092214050212800_bib33","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1128\/JCM.00370-08","article-title":"Multicenter comparison of PCR assays for detection of human herpesvirus 6 DNA in serum","volume":"46","author":"Flamand","year":"2008","journal-title":"J\u00a0Clin Microbiol"},{"issue":"23","key":"2023092214050212800_bib34","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1182\/blood.2020009362","article-title":"Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis","volume":"137","author":"Goldsmith","year":"2021","journal-title":"Blood"},{"issue":"2","key":"2023092214050212800_bib35","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/tid.12365","article-title":"Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis","volume":"17","author":"Crocchiolo","year":"2015","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"2023092214050212800_bib36","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3324\/haematol.2020.271445","article-title":"Comparison of immune reconstitution between anti-T-lymphocyte globulin and posttransplant cyclophosphamide as acute graft-versus-host disease prophylaxis in allogeneic myeloablative peripheral blood stem cell transplantation","volume":"107","author":"Massoud","year":"2022","journal-title":"Haematologica"},{"issue":"12","key":"2023092214050212800_bib37","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/s41409-018-0225-2","article-title":"HHV-6B infection, T-cell reconstitution, and graft-vs-host disease after hematopoietic stem cell transplantation","volume":"53","author":"Phan","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2023092214050212800_bib38","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1182\/blood-2002-03-0993","article-title":"Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity","volume":"101","author":"Boeckh","year":"2003","journal-title":"Blood"},{"issue":"7","key":"2023092214050212800_bib39","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood.V83.7.1971.1971","article-title":"Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis","volume":"83","author":"Li","year":"1994","journal-title":"Blood"},{"issue":"2","key":"2023092214050212800_bib40","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3324\/haematol.2019.229252","article-title":"Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation","volume":"106","author":"Wagner-Drouet","year":"2021","journal-title":"Haematologica"},{"key":"2023092214050212800_bib41","doi-asserted-by":"crossref","unstructured":"Tassi\n              E\n            , NovielloM, De SimoneP, . Cytomegalovirus specific T cells restricted for shared and donor human leukocyte antigens differentially impact on cytomegalovirus reactivation risk after allogeneic-hematopoietic stem cell transplantation. Haematologica. Published online 6 October 2022. https:\/\/doi.org\/10.3324\/haematol.2022.280685.","DOI":"10.3324\/haematol.2022.280685"},{"issue":"4","key":"2023092214050212800_bib42","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.immuni.2008.07.017","article-title":"Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells","volume":"29","author":"Snyder","year":"2008","journal-title":"Immunity"},{"issue":"13","key":"2023092214050212800_bib43","doi-asserted-by":"crossref","first-page":"e02321-18","DOI":"10.1128\/JVI.02321-18","article-title":"Phenotypic and functional differences between human herpesvirus 6- and human cytomegalovirus-specific T\u00a0cells","volume":"93","author":"Fastenackels","year":"2019","journal-title":"J\u00a0Virol"},{"key":"2023092214050212800_bib44","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.coviro.2014.10.001","article-title":"Immune response to HHV-6 and implications for immunotherapy","volume":"9","author":"Becerra","year":"2014","journal-title":"Curr Opin Virol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/18\/5446\/2079891\/blooda_adv-2022-009274-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/18\/5446\/2079891\/blooda_adv-2022-009274-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T10:06:03Z","timestamp":1695377163000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/18\/5446\/495382\/Human-herpesvirus-6-specific-T-cell-immunity-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":44,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2023,9,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022009274","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]}}}